Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams

Pediatrics

Volumn 106, Issue 4 I, 2000, Pages 700-706

  Franz, Axel R ^a,b   Mihatsch, Walter A ^a   Sander, Silvia ^a   Kron, Martina ^a   Pohlandt, Frank ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Blood transfusion; Iron deficiency; Iron supplementation; Preterm infant

Indexed keywords

ERYTHROPOIETIN; FERRITIN; FERROUS SULFATE; IRON; TRANSFERRIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; INFANT; IRON DEFICIENCY; IRON THERAPY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT;

EID: 0033776520     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.4.700     Document Type: Article

References (48)

1. Chemical development in utero
2. Plasma ferritin concentrations in preterm infants in cord blood and during the early anaemia of prematurity
3. At what age does iron supplementation become necessary in low-birth-weight infants?
4. When is iron supplementation appropriate for the extremely low birth weight infant?
5. Nutritional needs of low-birth-weight infants
6. Iron absorption and red blood cell incorporation in premature infants fed an iron-fortified infant formula
7. Iron fortification of infant formulas
8. Haemoglobin concentration depends on protein intake in small preterm infants fed human milk
9. Measured versus calculated latent iron binding capacity in plasma of newborns
10. Ferritin in serum: Diagnosis of iron deficiency and iron overload in infants and children
11. Developmental changes in red blood cell counts and indices of infants after exclusion of iron deficiency by laboratory criteria and continuous iron supplementation
12. Serum ferritin in assessment of iron nutrition in healthy infants
13. Nutritional anemias
14. Screening strategies for nutritional iron deficiency
15. Iron deficiency in infancy and childhood
16. Recommendations to prevent and control iron deficiency in the United States
17. The CRIB (Clinical Risk Index for Babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units
18. Parenteral iron increases serum erythropoietin concentration during the early anaemia' of 10-20-day-old mice
19. The 'early anaemia'; its relation to postnatal growth rate, milk feeding, and iron availability: Experimental study in rabbits
20. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants
21. Blood sampling in very low birth weight infants receiving different levels of intensive care
22. Factors related to transfusion in very low birthweight infants treated with erythropoietin
23. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group
24. Recombinant human erythropoietin in neonatal anemia
25. Assessment of anemia in newborn infants
26. Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants
27. Iron status in low birth weight infants on breast and formula feeding
28. Iron deficiency: Definition and diagnosis
29. Relationship of maternal and infant iron stores as assessed by determination of plasma ferritin
30. Developmental changes in serum iron, total iron-binding capacity, and transferrin saturation in infancy
31. Serum iron concentration and transferrin saturation in the diagnosis of iron deficiency in children: Normal developmental changes
32. Gestational age-dependent reference values for iron and selected proteins of iron metabolism m serum of premature human neonates
33. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
34. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'
35. Role of free radicals and catalytic metal ions in human disease: An overview
36. Blood transfusion. Iron load and retinopathy of prematurity
37. Antioxidant activity, packed cell transfusions, and outcome in premature infants
38. Blood transfusion and chronic lung disease in preterm infants
39. Iron containing feeding formula and oxidative stress in preterm babies
40. Long-term developmental outcome of infants with iron deficiency
41. Prevention of iron deficiency and psychomotor decline in high-risk infants through use of iron-fortified infant formula: A randomized clinical trial
42. Lack of adverse reactions to iron-fortified formula
43. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants
44. Iron-fortified formulas and gastrointestinal symptoms in infants: A controlled study
45. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake
46. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition
47. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
48. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study